India

CureBay Secures $10.6 Mn to Expand Rural Clinics and Strengthen AI Healthcare

Oct 22, 2026 | By Nguyen Minh

CureBay Secures $10.6 Mn

CureBay, an Indian healthtech startup focused on rural healthcare, has Secures approximately $10.6 million in a Pre-Series C funding round led by IvyCap Ventures, with participation from existing investors and debt providers. The company will use the fresh capital to expand its clinic network, enter new markets and strengthen its artificial intelligence (AI) capabilities.

CureBay Funding Details

The funding round includes more than ₹69 crore in equity and approximately ₹30 crore in debt. Trifecta Capital, Alteria Capital and VentureSoul Partners are providing the debt financing.

Before this round, CureBay had Secures more than $34.6 million from investors including Bertelsmann India Investments, British International Investment and Elevar Equity. In May 2025, the company raised $21 million in a Series B round led by Bertelsmann India Investments, with participation from Elevar Equity and British International Investment.

How Will CureBay Use the Funding?

CureBay plans to use the investment to strengthen its healthcare delivery network and expand into additional markets, including Telangana and Andhra Pradesh.

The company currently operates across several Indian states, including Odisha, Chhattisgarh, Jharkhand and Bihar. It aims to increase its rural clinic network from approximately 250 to 800 locations over the next two to three years.

The startup will also invest in computing infrastructure, including graphics processing units (GPUs), and train AI models to improve patient screening and health-risk assessments. Its existing AI-based screening tools cover areas such as skin conditions, dental health and haemoglobin levels.

CureBay’s Healthcare Services

Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain, CureBay connects patients in underserved communities with healthcare services through technology-enabled clinics, community health workers and digital platforms.

Its services include doctor consultations, diagnostic tests, medicines, surgery facilitation and annual health memberships. The platform connects patients with doctors, hospitals, laboratories and pharmacies to improve access to medical care in rural areas.

Revenue Growth and Profitability

CureBay reported annual recurring revenue (ARR) of nearly ₹170 crore in FY26, according to co-founder and CEO Priyadarshi Mohapatra. The company aims to double this figure by the end of FY27.

Mohapatra also said the startup achieved operating EBITDA break-even in FY26. Its monthly revenue run rate was approximately ₹20 crore at the time of his statement.

About CureBay

About CureBay company

CureBay is an India-based healthtech company founded in 2021 to improve access to healthcare in rural and underserved communities. It combines physical clinics, digital healthcare services, community health workers and AI-assisted screening tools to connect patients with medical professionals and healthcare facilities.

The company also works with government healthcare initiatives and has been named a healthcare partner for Samriddhi Kendra, a Government of India initiative.

Read Also - Vintage Investment Partners Secures $920 Mn in New Capital

Recommended Stories for You